Aviado · Research
Longevity Daily
Wednesday, June 17, 2026
Listen
Today's Brief
Today's pivotal story is the first human dose of an epigenetic reprogramming drug — a genuine milestone in longevity medicine. A major Nature Medicine study shows that plasma proteins can now pinpoint which of your cell types are aging fastest, previewing organ-level biological clocks from a single blood draw. A 20-year JAMA trial delivers a clear verdict: intensive lifestyle change cuts multimorbidity risk by 25% in prediabetes while metformin falls short. And new research finds that feeling lonely accelerates cognitive decline more powerfully than being objectively isolated.
10 stories7 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Feeling Lonely Accelerates Cognitive Decline Faster Than Actual Social Isolation
New research finds that the subjective experience of loneliness -- not objective social isolation -- is a more powerful driver of cognitive impairment and shortened lifespans in older adults. This distinction matters: you can be surrounded by people and still carry the cognitive risks of loneliness, while living alone does not automatically threaten your brain health. If social connection is a priority for cognitive longevity, quality and depth of relationships counts far more than sheer quantity.
Read more →Supplements & Compounds
Common Amino Acid Supplement Linked to Shorter Lifespans in Men
A study published in Aging-US found that men with higher circulating levels of tyrosine -- an amino acid found in many pre-workout and cognitive support supplements -- faced significantly shorter lifespans. The association was sex-specific and did not appear in women, suggesting hormonal or metabolic differences may mediate the risk. The data is observational (correlation ≠ causation), but men who regularly supplement tyrosine or eat very high-protein diets should treat this as a flag worth discussing with their physician.
Read more →The Next NAD+ Frontier: Block Its Breakdown, Don't Just Boost It
Emerging science presented at a major NAD+ metabolism conference is shifting the conversation from simply raising NAD+ levels with NMN or NR to preventing its degradation -- and the CD38 enzyme is the central target. CD38 activity rises sharply with age and breaks down NAD+ faster than most supplementation protocols can replace it. Botanical inhibitors of CD38 are now being positioned as a complementary -- and potentially more efficient -- strategy for preserving NAD+ in aging tissue.
Read more →Research & Papers
First Human Dosed With Epigenetic Reprogramming Drug in Landmark Longevity Trial
Life Biosciences, a Boston biotech linked to David Sinclair's foundational research, has administered the first human dose of a cellular rejuvenation drug -- the first FDA-cleared clinical trial of epigenetic reprogramming in humans. The trial targets glaucoma patients, using gene-based techniques to reprogram aging retinal cells to behave as younger cells again, with vision restoration as the immediate proof-of-concept. Epigenetic reprogramming has produced striking results in animal models -- reversing age-related decline across multiple tissue types -- but has never been tested in a human until now. If safety is established, researchers plan to extend the approach to other aging-related conditions throughout the body.
Read more →A Blood Test Can Now Estimate the Biological Age of 40+ Individual Cell Types
A landmark study in Nature Medicine demonstrates that plasma proteomics -- measuring thousands of proteins in a single blood sample -- can estimate the biological age of more than 40 distinct cell types throughout the body. Individuals whose specific cell types showed accelerated aging faced meaningfully higher disease risk tied to those tissue types. This represents a significant leap toward personalized aging diagnostics: a future where one blood draw reveals not just your overall biological age, but which organ systems are running ahead of schedule.
Read more →Scientists Identify a New Molecular Driver of Inflammaging -- and Block It With an Existing Drug
MD Anderson researchers discovered that senescent cells export RNA-DNA hybrid structures called R-loops into the cytoplasm via a protein called XPO1, activating the SASP inflammatory cascade that drives systemic aging inflammation. Blocking XPO1 with the drug selinexor in preclinical models suppressed inflammaging, reduced liver fibrosis, reversed body composition changes, and extended healthspan. Published in Nature Aging, the findings identify a new molecular pathway in age-related inflammation -- and one that may already be addressable with a compound in clinical use for cancer.
Read more →Aviado Research: In-Depth Analysis on the Latest in Longevity Science
Aviado Research's latest piece applies its evidence-first framework to the longevity findings that matter most to health-optimizing readers -- separating well-supported interventions from overhyped claims and flagging the nuances that mainstream coverage tends to miss.
Read the full Aviado analysis →Lifestyle & Nutrition
20-Year JAMA Trial: Lifestyle Change Cuts Multimorbidity Risk 25% in Prediabetes -- Metformin Does Not
Long-term follow-up from the Diabetes Prevention Program -- spanning two decades -- shows that adults with prediabetes who adopted intensive lifestyle changes were 25% less likely to develop multiple chronic conditions than those in the placebo group. Those randomized to metformin showed no statistically significant reduction in multimorbidity risk, directly challenging the drug's appeal as a lifestyle substitute. For the tens of millions living with prediabetes, this is among the strongest signals yet that behavior change is the intervention -- not a pharmaceutical placeholder for it.
Read more →Who You Live With Shapes Your Gut Microbiome -- Including Diabetes-Linked Bacteria
A new study finds that cohabitation -- not shared genetics -- is the dominant driver of strain-level gut and oral microbiome similarity between household members. This means you can effectively transmit microbial profiles, including bacteria associated with type 2 diabetes risk, simply by living together. For households focused on metabolic health, the implication is significant: dietary and lifestyle improvements may reshape the microbial ecosystem for the whole household, not just the individual making the changes.
Read more →